Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| EWP 815 | C12H22N4S4 | 20231-01-0 | Details |
| Eflucimibe | C29H43NO2S | 202340-45-2 | Details |
| 2,4-D-d3 | C8H3Cl2D3O3 | 202480-67-9 | Details |
| (R)-Azasetron besylate | C17H20ClN3O3.C6H6O3S | 2025360-91-0 | Details |
| Ticalopride | C14H20ClN3O3 | 202590-69-0 | Details |
| BMS-195270 | C15H9ClF3N3O2 | 202822-23-9 | Details |
| Morolimumab | 202833-07-6 | Details |
| Atorolimumab | 202833-08-7 | Details |
| XMU-MP-3 | C27H27F3N8O | 2031152-08-4 | Details |
| XMU-MP-2 | C32H33F3N8O2 | 2031152-10-8 | Details |
| Iscalimab | 2031153-61-2 | Details |
| PDD00031705 | C20H22N6O3S3 | 2032096-45-8 | Details |
| IRAK4-IN-8 | C23H23F2N7O2S | 2033070-97-0 | Details |
| Levilimab | 2035008-70-7 | Details |
| BAY 1892005 | C11H8ClFN2OS | 2036352-13-1 | Details |
| beta-Endosulfan-d4 | C9H2Cl6D4O3S | 203716-99-8 | Details |
| Iroxanadine | C14H20N4O | 203805-20-3 | Details |
| Allopregnanolone-d4 | C21H30D4O2 | 203805-85-0 | Details |
| Vopratelimab | 2039148-04-2 | Details |
| BI-6901 | C23H27N5O3S | 2040401-92-9 | Details |
| Coleneuramide | C39H68N2O8 | 204200-47-5 | Details |
| Kras4B G12D-IN-1 | C16H21ClN2O4S | 2042365-85-3 | Details |
| AZ506 | C33H40N6O | 2043321-54-4 | Details |
| Abrezekimab | 2043952-59-4 | Details |
| Tepoditamab | 2044679-53-8 | Details |
| Seclidemstat mesylate | C21H27ClN4O7S2 | 2044953-70-8 | Details |
| FD223 | C17H12ClN5O2S | 2050524-24-6 | Details |
| Ravagalimab | 2050816-56-1 | Details |
| Avexitide acetate | C149H234N40O47S.3C2H4O2 | 2051593-46-3 | Details |
| Izencitinib | C22H26N8 | 2051918-33-1 | Details |
| BTX161 | C15H16N2O3 | 2052301-24-1 | Details |
| Upacicalcet sodium | C11H15ClN3NaO6S | 2052969-18-1 | Details |
| TNF-α-IN-9 | C17H14O4 | 2054199-25-4 | Details |
| BTM-3528 | C24H19F4N3O2S2 | 2054998-45-5 | Details |
| Lenvervimab | 2055006-79-4 | Details |
| BMS-986224 | C24H23ClN4O6 | 2055200-88-7 | Details |
| Mal-amido-PEG3-NHS ester | C20H27N3O10 | 2055353-77-8 | Details |
| Nesuparib | C23H24N6O | 2055357-64-5 | Details |
| Tuvatexib | C21H23NO3 | 2055404-90-3 | Details |
| ERK-IN-3 benzenesulfonate | C28H31ClFN7O5S | 2055597-39-0 | Details |
| Mitazalimab | 2055640-86-1 | Details |
| Claficapavir | C17H12ClNO4S2 | 2055732-24-4 | Details |
| PF-06445974 | C20H15FN4O | 2055776-17-3 | Details |
| S5A1 | C27H33N3O4.ClH | 2055882-51-2 | Details |
| Osocimab | 2056878-75-0 | Details |
| WAY-239196 | C13H12N2O3 | 205749-56-0 | Details |
| Murlentamab | 2058047-65-5 | Details |
| Epratuzumab | 205923-57-5 | Details |
| Etigilimab | 2044984-83-8 | Details |
| K67 | C29H30N2O7S2 | 2046250-48-8 | Details |
| Sutimlimab | 2049079-64-1 | Details |
| AM-8123 | C27H33N7O5S | 2049973-02-4 | Details |
| Azelaprag | C25H29N7O4S | 2049980-18-7 | Details |
| Cetrelimab | 2050478-92-5 | Details |
| (Rac)-LB-100 | 2061038-65-9 | Details |
| Belantamab | 2061894-48-0 | Details |
| Tovinontrine | C21H26N6O2 | 2062661-53-2 | Details |
| Tilpisertib | C33H33ClN8O | 2065153-41-3 | Details |
| Orilanolimab | 2066544-85-0 | Details |
| PF-06843195 | C20H25F3N8O4 | 2067281-51-8 | Details |
| USP30 inhibitor 11 | C17H16N6O2S | 2067332-64-1 | Details |
| EGFR-IN-99 | C25H22FN7O3 | 2068806-31-3 | Details |
| Pitavastatin D4 | C??H??D?FNO? | 2070009-71-9 | Details |
| SR9011 hydrochloride | C??H??Cl?N?O?S | 2070014-94-5 | Details |
| UNC2025 hydrochloride | C28H41ClN6O | 2070015-17-5 | Details |
| MAX-40279 | C22H23FN6OS | 2070931-57-4 | Details |
| TBI-223 | C17H20FN3O5 | 2071265-08-0 | Details |
| Sintilimab (anti-PD-1) | 2072873-06-2 | Details |
| HDAC-IN-52 | C24H20N4O2 | 2075787-77-6 | Details |
| D-Ribose 5-phosphate disodium dihydrate | C5H9Na2O8P2H2O | 207671-46-3 | Details |
| CMX-521 | C13H17N5O5 | 2077178-99-3 | Details |
| Casein Kinase inhibitor A86 | C18H25FN6 | 2079069-01-3 | Details |
| Retifanlimab | 2079108-44-2 | Details |
| TU-2100 | C27H32O8 | 207972-39-2 | Details |
| Pumafentrine | C29H39N3O3 | 207993-12-2 | Details |
| JHU395 | C22H29N3O7 | 2079938-92-2 | Details |
| Sirpiglenastat | C22H27N5O5 | 2079939-05-0 | Details |
| GSK3494245 | C21H23FN6O2 | 2080410-41-7 | Details |
| F13714 fumarate | 208109-39-1 | Details |
| Quetmolimab | 2084037-83-0 | Details |
| Tz-Thalidomide | C29H29N7O6 | 2087490-42-2 | Details |
| Lingdolinurad | C17H12BrN3O2 | 2088176-96-7 | Details |
| SM1-71 | C24H26ClN7O | 2088179-99-9 | Details |
| Brentuximab | 2088770-90-3 | Details |
| Anticancer agent 7 | C24H19Cl2F3N2O5S | 2088956-21-0 | Details |
| PSB-16133 sodium | C28H23N2NaO5S2 | 2089035-40-3 | Details |
| Rolusafine | C19H18N2O2 | 2089153-78-4 | Details |
| Golexanolone | C21H31NO2 | 2089238-18-4 | Details |
| VT-1598 | C31H20F4N6O2 | 2089320-99-8 | Details |
| Palazestrant | C28H36FN3O | 2092925-89-6 | Details |
| OTS193320 | C28H30ClN5O4 | 2093401-33-1 | Details |
| Prolgolimab | 2093956-19-3 | Details |
| Cinpanemab | 2094516-02-4 | Details |
| Posenacaftor sodium | C27H28NNaO5 | 2095064-06-3 | Details |
| (R)-Posenacaftor sodium | C27H28NNaO5 | 2095064-09-6 | Details |
| PFB-FDGlu | C39H32F5NO16 | 209540-62-5 | Details |
| PU-H71 HCl | C18H22ClIN6O2S | 2095432-24-7 | Details |
| GSK269962A hydrochloride | C29H31ClN8O5 | 2095432-71-4 | Details |
| Rolinsatamab | 2095467-30-2 | Details |
| TV 3279 | C16H20N2O2 | 209394-29-6 | Details |
| Product Total： Product Page： | ||||
| 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||